Pathway Diagnostics
Jump to navigation
Jump to search
Pathway Diagnostics "is an innovator in the development of novel biomarker assays. Integrating biomarker testing services for pharma clinical trials with a growing portfolio of proprietary assay technology, we aim to bring to market the next generation of diagnostic tools. Our corporate headquarters and laboratory comprise 20,000 square feet of a landmark technology office park campus in Malibu, California." [1]
Contents
People
Accessed December 2007: [2]
Senior Officers
- Wally Narajowski, President & Chief Executive Officer
- Bart E. Thielen, Chief Financial Officer
- Joseph Lanfreschi, Ph.D., VP of Laboratory & Clinical Trials Operations
- Terry Robins, Ph.D., VP of Research & Development
- Stephanie H. Astrow, Ph.D., MBA, VP, Director of Oncology
- Allen R. Gehrke, National Sales Director, Clinical Trials
Directors
- Lionel Carnot, Director
- Richard Daly, Director
- E. Rolland Dickson, M.S., M.D., Director
- William G. Gerber, M.D., Chairman
- David V. Milligan, Ph.D., Director
- Wally Narajowski, President & Chief Executive Officer
- Nicholas J. Pritzker, Director
